IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests 'Living Drug' for tough autoimmune cases
Disease control Recruiting nowThis is an early safety study to test a new type of treatment called LUCAR-G79D, a CAR-T cell therapy, in adults with severe lupus or inflammatory muscle disease that has not responded to other treatments. The main goal is to see if the treatment is safe, how the body handles it,…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Phase: PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Radical cell therapy tested for Tough-to-Treat autoimmune illnesses
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of a new cell therapy called BZE2204 for adults with severe autoimmune diseases that have not improved with standard treatments. The therapy involves modifying a patient's own immune cells to target and potent…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated Mar 06, 2026 15:39 UTC